Document Detail

Successful treatment by defibrination with ancrod in a patient with hyperacute renal allograft failure and a deficiency of plasma prostacyclin stimulating factor.
MedLine Citation:
PMID:  6754189     Owner:  NLM     Status:  MEDLINE    
Hyperacute and renal allograft failure, whether due to rejection or other mechanisms, such as perfusion injury, is usually associated with extensive intraglomerular fibrin deposition and allograft loss. Defibrination with ancrod was used to treat a patient with hyperacute renal allograft failure and extensive glomerular fibrin deposition and necrosis. The patient's plasma had normal fibrinolytic activity but a complete absence of the ability to generate prostacyclin-like activity from rat aortic endothelium "in vitro". Treatment was associated with complete recovery of renal function, disappearance of glomerular fibrin, and restoration toward normal of glomerular structure.
A K Dosekun; M R First; P K Chandran; K S Kant; P Glas-Greenwalt; M A Weiss; J W Alexander; V E Pollak
Related Documents :
24775009 - Defibrillator implantation for the primary prevention of sudden death in patients await...
23255039 - A road map for patients with imminent end-stage renal disease.
8173899 - Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in rena...
18325189 - Balance of transforming growth factor-beta1 and platelet-derived growth factor-bb is as...
23164419 - Reversible left ventricular dysfunction and acute kidney injury in a patient with nonam...
10935699 - Endothelin-1, endothelin-3 and their receptors (endothelin(a) and endothelin(b)) in chr...
22533649 - Phenotypes of antibody-mediated rejection in organ transplants.
6662649 - Ipsilateral ureteroureterostomy in the management of duplicated collecting system and u...
9119739 - Overexpression of integrin-associated protein (cd47) in rat kidney treated with a renal...
Publication Detail:
Type:  Case Reports; In Vitro; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Clinical nephrology     Volume:  18     ISSN:  0301-0430     ISO Abbreviation:  Clin. Nephrol.     Publication Date:  1982 Aug 
Date Detail:
Created Date:  1983-01-19     Completed Date:  1983-01-19     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0364441     Medline TA:  Clin Nephrol     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  101-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Ancrod / pharmacology,  therapeutic use*
Biological Products / analysis,  deficiency*
Epoprostenol / blood,  deficiency*
Fibrin / analysis
Graft Rejection / drug effects*
Kidney / pathology
Kidney Diseases / blood,  drug therapy*,  pathology
Kidney Glomerulus / analysis,  pathology
Kidney Transplantation*
Prostaglandins / deficiency*
Grant Support
Reg. No./Substance:
0/Biological Products; 0/Prostaglandins; 35121-78-9/Epoprostenol; 9001-31-4/Fibrin; EC 3.4.21.-/Ancrod

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Renin synthesis and gene cloning.
Next Document:  Kidney graft survival: role of blood transfusions and lymphocytotoxic antibodies.